Cumberland Pharmaceuticals's total assets for Q1 2025 were $69.94M, a decrease of -7.47% from the previous quarter. CPIX total liabilities were $41.60M for the fiscal quarter, a -21.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.